This is a characteristic for types of disease other than primary amyloidosis (AL) including secondary (AA), familial with genetically variant transthyretin (ATTR), amyloidosis associated with dialysis (Aβ2M), as well as Aβ and AIAPP forms. This evidence concerns the gene TTR and AL amyloidosis.